SERA (SERA) Stock Price & Analysis
SERA (SERA) fell 0.49% to USD 2.01 as of September 8, 2026 at 21:30 UTC, according to Nexqual real-time market data.
SERA last closed at USD 2.01; the session ranged USD 1.98–2.04 on volume of 64,073 shares. Market capitalization is —, with a 52-week range of USD 1.56–3.95 (NGM). Source: Nexqual, September 8, 2026 at 21:30 UTC.
Key Statistics (as of September 8, 2026 at 21:30 UTC)
| Price | USD 2.01 |
|---|---|
| Change | ▼ 0.49% (down) |
| Previous Close | USD 2.01 |
| Open | USD 2.01 |
| Day Range | USD 1.98 – 2.04 |
| 52-Week Range | USD 1.56 – 3.95 |
| Volume | 64,073 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (SERA)
Nexqual's technical model rates SERA "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 21:30 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.31 (neutral) |
| vs SMA50 | Below (USD 2.04) |
| MACD | -0 (negative) |
From SERA's Latest SEC 10-K Filing (filed 2026-03-18)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INAB | IN8bio, Inc. | USD 1.14 | ▼ 1.72% |
| NEXI | NexImmune, Inc. | USD 0 | ▲ 0% |
| TCRX | TScan Therapeutics, Inc. | USD 0.34 | ▼ 7.06% |
| SGHT | Sight Sciences, Inc. | USD 8.1 | ▼ 3.34% |
| SNTG | Sentage Holdings Inc. | USD 1.7 | ▼ 2.3% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 21:30 UTC. This page is informational and not investment advice.